United States Biotechnology & Medical Research

Histogen Inc (HSTO)

Track

Track

Ticker: HSTO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.5
Pascoe Richard W President, CEO & Director Executive Director
Transaction date
Purchase
Price
261.27
Quantity 88,183 -29.7%
Value US$4,281,470
3.5
Pascoe Richard W President, CEO & Director Executive Director
Transaction date
Purchase
Price
289.08
Quantity 20,472 +42.8%
Value US$3,741,495
KISNER DANIEL L Non-Executive Director
Transaction date
Purchase
Price
157.62
Quantity 12,267 +2.7%
Value US$2,068,000
LACASSE LOUIS P Non-Executive Director
Transaction date
Purchase
Price
11.00
Quantity 123,950 +18.1%
Value US$1,363,450
Scopa James Paul Non-Executive Director
Transaction date
Purchase
Price
11.00
Quantity 165,265 +16.1%
Value US$1,817,915
ADVENT VENTURE PARTNERS LLP Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 190,054 +9.6%
Value US$2,090,594
ADVENT VENTURE PARTNERS LLP Large shareholder
Transaction date
Sale
Price
11.00
Quantity 535 -0.0%
Value US$5,885
Aberdare GP III, L.L.C. Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 2,470 +4.9%
Value US$27,170
Aberdare GP III, L.L.C. Large shareholder
Transaction date
Sale
Price
11.00
Quantity 14 -0.0%
Value US$154
Aberdare GP III, L.L.C. Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 104,952 +4.9%
Value US$1,154,472
Aberdare GP III, L.L.C. Large shareholder
Transaction date
Sale
Price
11.00
Quantity 552 -0.0%
Value US$6,072
COOPERATIVE GILDE HEALTHCARE II U.A. Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 165,525 +12.5%
Value US$1,820,775
COOPERATIVE GILDE HEALTHCARE II U.A. Large shareholder
Transaction date
Sale
Price
11.00
Quantity 352 -0.0%
Value US$3,872
MPM BioVentures IV QP LP Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 165,265 +16.1%
Value US$1,817,915
Perret Marc Olivier Non-Executive Director Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 165,525 +12.5%
Value US$1,820,775
Perret Marc Olivier Non-Executive Director Large shareholder
Transaction date
Sale
Price
11.00
Quantity 352 -0.0%
Value US$3,872
Malik Shahzad Non-Executive Director Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 190,054 +9.6%
Value US$2,090,594
Malik Shahzad Non-Executive Director Large shareholder
Transaction date
Sale
Price
11.00
Quantity 535 -0.0%
Value US$5,885
EVNIN LUKE Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 165,265 +16.1%
Value US$1,817,915
KLINGENSTEIN PAUL H Non-Executive Director Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 2,470 +4.9%
Value US$27,170
KLINGENSTEIN PAUL H Non-Executive Director Large shareholder
Transaction date
Sale
Price
11.00
Quantity 14 -0.0%
Value US$154
KLINGENSTEIN PAUL H Non-Executive Director Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 104,952 +4.9%
Value US$1,154,472
KLINGENSTEIN PAUL H Non-Executive Director Large shareholder
Transaction date
Sale
Price
11.00
Quantity 552 -0.0%
Value US$6,072
HALE DAVID F Non-Executive Director
Transaction date
Purchase
Price
11.00
Quantity 2,588 +1.8%
Value US$28,468
Mento Steven J President, CEO & Director Executive Director
Transaction date
Purchase
Price
11.00
Quantity 13,800 +3.7%
Value US$151,800
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-03-30 2021-03-30 B Purchase
3.5
Pascoe Richard W

President, CEO & Director

Executive Director
88,183 -29.7%
261.27
US$4,281,470 		88,183 -29.7% 261.27 US$4,281,470
2020-12-07 2020-12-03 B Purchase
3.5
Pascoe Richard W

President, CEO & Director

Executive Director
20,472 +42.8%
289.08
US$3,741,495 		20,472 +42.8% 289.08 US$3,741,495
2015-04-10 2015-04-08 B Purchase KISNER DANIEL L Non-Executive Director
12,267 +2.7%
157.62
US$2,068,000 		12,267 +2.7% 157.62 US$2,068,000
2013-08-01 2013-07-30 B Purchase LACASSE LOUIS P Non-Executive Director
123,950 +18.1%
11.00
US$1,363,450 		123,950 +18.1% 11.00 US$1,363,450
2013-08-01 2013-07-30 B Purchase Scopa James Paul Non-Executive Director
165,265 +16.1%
11.00
US$1,817,915 		165,265 +16.1% 11.00 US$1,817,915
2013-08-01 2013-07-30 B Purchase ADVENT VENTURE PARTNERS LLP Large shareholder
190,054 +9.6%
11.00
US$2,090,594 		190,054 +9.6% 11.00 US$2,090,594
2013-08-01 2013-07-30 S Sale ADVENT VENTURE PARTNERS LLP Large shareholder
535 -0.0%
11.00
US$5,885 		535 -0.0% 11.00 US$5,885
2013-08-01 2013-07-30 B Purchase Aberdare GP III, L.L.C. Large shareholder
2,470 +4.9%
11.00
US$27,170 		2,470 +4.9% 11.00 US$27,170
2013-08-01 2013-07-30 S Sale Aberdare GP III, L.L.C. Large shareholder
14 -0.0%
11.00
US$154 		14 -0.0% 11.00 US$154
2013-08-01 2013-07-30 B Purchase Aberdare GP III, L.L.C. Large shareholder
104,952 +4.9%
11.00
US$1,154,472 		104,952 +4.9% 11.00 US$1,154,472
2013-08-01 2013-07-30 S Sale Aberdare GP III, L.L.C. Large shareholder
552 -0.0%
11.00
US$6,072 		552 -0.0% 11.00 US$6,072
2013-08-01 2013-07-30 B Purchase COOPERATIVE GILDE HEALTHCARE II U.A. Large shareholder
165,525 +12.5%
11.00
US$1,820,775 		165,525 +12.5% 11.00 US$1,820,775
2013-08-01 2013-07-30 S Sale COOPERATIVE GILDE HEALTHCARE II U.A. Large shareholder
352 -0.0%
11.00
US$3,872 		352 -0.0% 11.00 US$3,872
2013-08-01 2013-07-30 B Purchase MPM BioVentures IV QP LP Large shareholder
165,265 +16.1%
11.00
US$1,817,915 		165,265 +16.1% 11.00 US$1,817,915
2013-08-01 2013-07-30 B Purchase Perret Marc Olivier Non-Executive Director Large shareholder
165,525 +12.5%
11.00
US$1,820,775 		165,525 +12.5% 11.00 US$1,820,775
2013-08-01 2013-07-30 S Sale Perret Marc Olivier Non-Executive Director Large shareholder
352 -0.0%
11.00
US$3,872 		352 -0.0% 11.00 US$3,872
2013-08-01 2013-07-30 B Purchase Malik Shahzad Non-Executive Director Large shareholder
190,054 +9.6%
11.00
US$2,090,594 		190,054 +9.6% 11.00 US$2,090,594
2013-08-01 2013-07-30 S Sale Malik Shahzad Non-Executive Director Large shareholder
535 -0.0%
11.00
US$5,885 		535 -0.0% 11.00 US$5,885
2013-08-01 2013-07-30 B Purchase EVNIN LUKE Large shareholder
165,265 +16.1%
11.00
US$1,817,915 		165,265 +16.1% 11.00 US$1,817,915
2013-08-01 2013-07-30 B Purchase KLINGENSTEIN PAUL H Non-Executive Director Large shareholder
2,470 +4.9%
11.00
US$27,170 		2,470 +4.9% 11.00 US$27,170
2013-08-01 2013-07-30 S Sale KLINGENSTEIN PAUL H Non-Executive Director Large shareholder
14 -0.0%
11.00
US$154 		14 -0.0% 11.00 US$154
2013-08-01 2013-07-30 B Purchase KLINGENSTEIN PAUL H Non-Executive Director Large shareholder
104,952 +4.9%
11.00
US$1,154,472 		104,952 +4.9% 11.00 US$1,154,472
2013-08-01 2013-07-30 S Sale KLINGENSTEIN PAUL H Non-Executive Director Large shareholder
552 -0.0%
11.00
US$6,072 		552 -0.0% 11.00 US$6,072
2013-08-01 2013-07-30 B Purchase HALE DAVID F Non-Executive Director
2,588 +1.8%
11.00
US$28,468 		2,588 +1.8% 11.00 US$28,468
2013-08-01 2013-07-30 B Purchase Mento Steven J

President, CEO & Director

Executive Director
13,800 +3.7%
11.00
US$151,800 		13,800 +3.7% 11.00 US$151,800
Explore more

More insider trading research around Histogen Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America